Jiali Peng
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Oncology
- Immunology
- Topics
- PARP inhibition in cancer therapy (3 papers)DNA Repair Mechanisms (2 papers)Cancer, Stress, Anesthesia, and Immune Response (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Jiali Peng
15 papers receiving 529 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Molecular Biology 314
- Pulmonary and Respiratory Medicine 278
- Cancer Research 229
- Oncology 69
- Immunology 41
Countries citing papers authored by Jiali Peng
This map shows the geographic impact of Jiali Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiali Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiali Peng more than expected).
Fields of papers citing papers by Jiali Peng
This network shows the impact of papers produced by Jiali Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiali Peng. The network helps show where Jiali Peng may publish in the future.
Co-authorship network of co-authors of Jiali Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Jiali Peng. A scholar is included among the top collaborators of Jiali Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiali Peng. Jiali Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 17 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 8 | |
| 7 | 31 | |
| 8 | 20 | |
| 9 | 36 | |
| 10 | CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer. | 30 |
| 11 | Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1breakdown → | 342 |
| 12 | 9 | |
| 13 | 13 | |
| 14 | 13 | |
| 15 | 3 |
About Jiali Peng
Jiali Peng is a scholar working on Anesthesiology and Pain Medicine, Internal Medicine and Obstetrics and Gynecology, having authored 15 papers that have together received 532 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (2 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). The work is most often cited by research in Cancer Research (229 citations), Pulmonary and Respiratory Medicine (278 citations) and Molecular Biology (314 citations). Jiali Peng has collaborated with scholars based in China and United States. Frequent co-authors include Hong Jiang, Hui Dong, Dongdong Chai, Rong Hu, Yangyang Xia, Beihua Kong, Gonghua Qi, Hanlin Ma, Yingwei Li and Fang Han. Their work appears in journals such as Frontiers in Immunology, Life Sciences and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.